EUVIMEDEUVIMED entdecken
Crossref

Perioperative complications of middle cerebral artery occlusion in rats alleviated by human umbilical cord mesenchymal stem cells

Liang Liu, Yating Luo, Tao Xu, Qisheng Tang, Jialian Yi, Linping Wang, Shixiang Luo, Zhaohong Bi, Jianlei Liu, Jun Lu, Weiwei Bi, Changguo Peng und 1 weitere

Naunyn-Schmiedeberg's Archives of Pharmacology · 2024

DOI: 10.1007/s00210-024-03269-3 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Naunyn-Schmiedeberg's Archives of Pharmacology, 2024. Verfasst von Liang Liu und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anesthesia, Changde Hospital, Xiangya School of Medicine, Central South University, Changde, 415000, Hunan, China. Hauptthemen laut MEDLINE: Mesenchymal Stem Cell Transplantation, Infarction, Middle Cerebral Artery, Rats, Sprague-Dawley, Umbilical Cord. Die Arbeit nennt 54 Literaturangaben. Gefördert von: Less Developed Regions of National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

For acute ischemic stroke treatment, the limitations of treatment methods and the high incidence of perioperative complications seriously affect the survival rate and postoperative recovery of patients. Human umbilical cord mesenchymal stem cells (hucMSCs) have multi-directional differentiation potential and immune regulation function, which is a potential cell therapy. The present investigation involved developing a model of cerebral ischemia-reperfusion injury by thrombectomy after middle cerebral artery occlusion (MCAO) for 90 min in rats and utilizing comprehensive multi-system evaluation methods, including the detection of brain tissue ischemia, postoperative survival rate, neurological score, anesthesia recovery monitoring, pain evaluation, stress response, and postoperative pulmonary complications, to elucidate the curative effect of tail vein injection of hucMSCs on MCAO's perioperative complications. Based on our research, it has been determined that hucMSCs treatment can reduce the volume of brain tissue ischemia, promote the recovery of neurological function, and improve the postoperative survival rate of MCAO in rats. At the same time, hucMSCs treatment can prolong the time of anesthesia recovery, relieve the occurrence of delirium during anesthesia recovery, and also have a good control effect on postoperative weight loss, facial pain expression, and lung injury. It can also reduce postoperative stress response by regulating blood glucose and serum levels of stress-related proteins including TNF-α, IL-6, CRP, NE, cortisol, β-endorphin, and IL-10, and ultimately promote the recovery of MCAO's perioperative complications.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Mesenchymal Stem Cell TransplantationInfarction, Middle Cerebral ArteryRats, Sprague-DawleyUmbilical CordAnimalsHumansMaleRatsMesenchymal Stem CellsDisease Models, AnimalPostoperative ComplicationsReperfusion Injury

Stichwörter der Autor:innen

AnesthesiaHuman umbilical cord mesenchymal stem cellsMiddle cerebral artery occlusionPerioperative complications

Autor:innen und Institutionen

  • Department of Anesthesia, Changde Hospital, Xiangya School of Medicine, Central South University, Changde, 415000, Hunan, China.
  • Guangdong Chanmeng Stem Cell Technologies Co., Ltd., Foshan, 528000, Guangdong, China.
  • Department of Anesthesiology, Shanghai Jiao Tong University Affiliated Sixth People's Hospital, Shanghai, 200233, China.
  • Regenerative Medicine Research Center of The First People's Hospital of Yunnan Province, Affiliated Hospital of Kunming University of Science and Technology, Xishan District, 157 Jinbi Road, Kunming, 650000, Yunnan, Chi…
  • Cell Therapy Engineering Research Center for Cardiovascular Diseases in Yunnan Province, Kunming, 650000, Yunnan, China.
  • Key Laboratory of Innovative Application for Traditional Chinese Medicine in Yunnan Province, Kunming, 650000, Yunnan, China.

Förderung

  • Less Developed Regions of National Natural Science Foundation of China

Zitieren

APA

Liu, L., Luo, Y., Xu, T., Tang, Q., Yi, J., Wang, L., Luo, S., Bi, Z., Liu, J., Lu, J., Bi, W., Peng, C., & Liu, J. (2024). Perioperative complications of middle cerebral artery occlusion in rats alleviated by human umbilical cord mesenchymal stem cells. Naunyn-Schmiedeberg's Archives of Pharmacology. https://doi.org/10.1007/s00210-024-03269-3

Vancouver

Liu L, Luo Y, Xu T, Tang Q, Yi J, Wang L, et al. Perioperative complications of middle cerebral artery occlusion in rats alleviated by human umbilical cord mesenchymal stem cells. Naunyn-Schmiedeberg's Archives of Pharmacology. 2024. doi:10.1007/s00210-024-03269-3

BibTeX
@article{Liu2024,
  author = {Liu, Liang and Luo, Yating and Xu, Tao and Tang, Qisheng and Yi, Jialian and Wang, Linping and Luo, Shixiang and Bi, Zhaohong and Liu, Jianlei and Lu, Jun and Bi, Weiwei and Peng, Changguo and Liu, Jie},
  title = {Perioperative complications of middle cerebral artery occlusion in rats alleviated by human umbilical cord mesenchymal stem cells},
  journal = {Naunyn-Schmiedeberg's Archives of Pharmacology},
  year = {2024},
  doi = {10.1007/s00210-024-03269-3}
}
Kostenlos starten →